CELECOXIB - Chemoradiation therapy for reducing mucositis and other acute side effects in advance head and neck carcinoma

CELECOXIB - Chemoradiation therapy for reducing mucositis and other acute side effects in advance head and neck carcinoma

"nBackground: Chemo-radiotherapy-induced oral mucositis represents a therapeutic challenge frequently encountered in cancer patients. This side effect causes significant morbidity and may delay or interruption of treatment plan, cyclo-oxygenase 2 (COX2) is an inducible enzyme primarily expr...

Full description

Bibliographic Details
Main Authors: Izadi Sh, Farhan F, Kazemian A, Aghili M, Mojahed MM
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2009-02-01
Series:Tehran University Medical Journal
Subjects:
Head and neck cancer
chemoradiation
acute toxicities
mucositis
COX-2
celecoxib
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/13220.pdf&manuscript_id=13220

Internet

http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/13220.pdf&manuscript_id=13220

Similar Items